APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 1 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,316,184 | +211.2% | 34,600 | +458.7% | 0.01% | +180.0% |
| Q3 2022 | $423,000 | +54.4% | 6,193 | +2.2% | 0.01% | +66.7% |
| Q2 2022 | $274,000 | -65.3% | 6,060 | -61.0% | 0.00% | -57.1% |
| Q1 2022 | $790,000 | -86.5% | 15,549 | -87.4% | 0.01% | -84.8% |
| Q4 2021 | $5,839,000 | -35.8% | 123,490 | -55.2% | 0.05% | -35.2% |
| Q3 2021 | $9,094,000 | -18.9% | 275,910 | +55.4% | 0.07% | -13.4% |
| Q2 2021 | $11,220,000 | – | 177,525 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |